2025 third_quarter Filing
Q3Lobbying Activities
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act and pharmacy benefit management. Issues related to mental health. Issues related to SUPPORT Act Reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.
Issues related to tariffs.